Molly Strattan, CNM
Advanced Practice Midwife · Tigard, ORNPI 1104903731
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.9% of the total across 240 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 34 manufacturers reported payments, led by AbbVie at 32.5% of the total. Among advanced practice midwife clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 240 payments — averaging $21.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- GSK$366
- Astellas Pharma US Inc$352
- Novo Nordisk$259
- Boehringer Ingelheim$255
- Lilly USA, LLC$228
- plus $2K from 28 others
What the payments were for
- Food & beverage$4,89197%
- Education$1563%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 90 | $1,642 |
| GSK | 7 | $366 |
| Astellas Pharma US Inc | 9 | $352 |
| Novo Nordisk | 15 | $259 |
| Boehringer Ingelheim | 11 | $255 |
| Lilly USA, LLC | 10 | $228 |
| Exact Sciences | 9 | $194 |
| AstraZeneca | 10 | $175 |
| Abbott | 7 | $162 |
| E.r. Squibb & Sons, L.L.C. | 9 | $158 |
| Otsuka America Pharmaceutical, Inc. | 7 | $136 |
| Aimmune Therapeutics, Inc. | 4 | $106 |
| Johnson & Johnson | 5 | $102 |
| Bayer | 5 | $95 |
| Sanofi-aventis U.S. LLC | 5 | $88 |
| Madrigal Pharmaceuticals | 1 | $83 |
| Organon | 6 | $82 |
| Pfizer | 4 | $78 |
| Merck | 3 | $57 |
| Phathom Pharmaceuticals, Inc. | 3 | $50 |
| Bausch Health US, LLC | 2 | $49 |
| Evofem Biosciences, Inc. | 2 | $47 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $39 |
| Bristol Myers Squibb | 2 | $33 |
| Therapeuticsmd, Inc. | 2 | $33 |
| Biohaven Pharmaceuticals, Inc. | 2 | $32 |
| Rhythm Pharmaceuticals, Inc. | 1 | $24 |
| Ironshore Pharmaceuticals Inc. | 1 | $24 |
| Nevro Corp. | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Lucid Diagnostics Inc. | 1 | $15 |
| Alkermes, Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SHINGRIX$116
How this compares
$5,047 in reported general payments places this provider in the 95th percentile of 144 advanced practice midwife providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 32 | $50,993 |
| FarxigaDapagliflozin Propanediol | 20 | $29,291 |
| JardianceEmpagliflozin | 11 | $16,133 |
| XareltoRivaroxaban | 17 | $14,085 |
| Estradiol | 57 | $6,220 |
| Levothyroxine Sodium | 181 | $2,657 |
| Bupropion XlBupropion Hcl | 51 | $1,783 |
| Atorvastatin Calcium | 109 | $1,461 |
| Irbesartan | 76 | $1,340 |
| Metformin Hcl ErMetformin Hcl | 99 | $1,288 |
| Losartan Potassium | 56 | $974 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 36 | $951 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 65 | $947 |
| Lisinopril | 86 | $666 |
| ProgesteroneProgesterone, Micronized | 21 | $653 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $259 | $50,99332 claims |
| AstraZenecaFarxiga | $175 | $29,29120 claims |
| Boehringer IngelheimJardiance | $255 | $16,13311 claims |
| Johnson & JohnsonXarelto | $102 | $14,08517 claims |
| AbbVieSynthroid | $1,642 | $33617 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 144 advanced practice midwife providers in Oregon.
Other advanced practice midwife in Tigard
- Michele MegregianPortland$36K
- Kirstin CarhartRoseburg$17K
- Renee BeningerPortland$5K
- Michelle BrookeyPortland$5K
- Jennifer Jagger KaeserPortland$2K
- Yvonne FenrichNorth Bend$1K
- Alina PalmerPortland$922
- Kendall Olson-CassidyMedford$664
- Peri VernonBend$643
- Julie AbbottCoos Bay$572
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.